Irving F. Lyons III - Aug 30, 2021 Form 4 Insider Report for EQUINIX INC (EQIX)

Role
Director
Signature
/s/ Samantha Lagocki, POA
Stock symbol
EQIX
Transactions as of
Aug 30, 2021
Transactions value $
-$6,924,586
Form type
4
Date filed
9/1/2021, 05:05 PM
Previous filing
Jul 21, 2021
Next filing
Nov 26, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EQIX Common Stock Gift $0 -8.25K -39.66% $0.00 12.6K Aug 30, 2021 Direct F1
transaction EQIX Common Stock Gift $0 +8.25K $0.00 8.25K Aug 30, 2021 Charitable Remainder Trust F1
transaction EQIX Common Stock Sale -$5.36M -6.38K -77.36% $839.16 1.87K Aug 30, 2021 Charitable Remainder Trust F2
transaction EQIX Common Stock Sale -$1.57M -1.87K -100% $839.97 0 Aug 30, 2021 Charitable Remainder Trust F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On August 30, 2021, the reporting person transferred 8,250 shares of Equinix common stock to a charitable remainder trust of which the reporting person is trustee and of which the reporting person and his spouse are beneficiaries. The reporting person continues to report beneficial ownership of all of the Equinix common stock held by the trust but disclaims beneficial ownership except to the extent of his and his spouse's pecuniary interest therein.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $838.7064 to $839.66, inclusive. The reporting person undertakes to provide to Equinix, Inc, any security holder of Equinix Inc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnote 2 to this Form 4.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $839.71 to $840.13 inclusive.